Abstract: The present disclosure relates to a method for recovering a metal or a metal compound, using genus Galdieria.

Abstract: Provided is a pharmaceutical for preventing or treating an ophthalmic disease associated with intraocular neovascularization and/or increased intraocular vascular permeability. The inventors of the present invention have made investigations on a pharmaceutical for preventing or treating an ophthalmic disease associated with intraocular neovascularization and/or increased intraocular vascular permeability, and have confirmed that a selective S1P receptor agonist having agonist activity at an S1P1 receptor has an intraocular neovascularization-reducing action and an intraocular vascular permeability-reducing action, thus completing the present invention.

Abstract: The present invention relates to a metal recovery agent or a metal compound recovery agent including: a dried matter of a cell or a cell derivative of the red algae belonging to the order Cyanidiales, or an artificial matter that imitates the dried matter. The present invention also relates to a method for recovering a metal or a metal compound including: an addition step of adding a dried matter of a cell or a cell derivative of the red algae belonging to the order Cyanidiales, or an artificial matter that imitates the dried matter to a metal solution; and an adsorption step of causing a metal or a metal compound contained in the metal solution to be adsorbed onto the cell or the cell derivative derived from the dried matter, or the artificial matter.

Abstract: Provided is a pharmaceutical composition which enables the inhibition of formation and/or enlargement of cerebral aneurysm or the regression of cerebral aneurysm. The pharmaceutical composition for the inhibition of formation and/or enlargement of cerebral aneurysm or for the regression of cerebral aneurysm of the present invention, which includes a S1P1 receptor agonist as an active ingredient, enables the inhibition of formation and/or enlargement of cerebral aneurysm or the regression of cerebral aneurysm, and enables the prevention and/or treatment of a disease associated with cerebral aneurysm.

Abstract: Provided is a pharmaceutical composition which enables the inhibition of formation and/or enlargement of cerebral aneurysm or the regression of cerebral aneurysm. The pharmaceutical composition for the inhibition of formation and/or enlargement of cerebral aneurysm or for the regression of cerebral aneurysm of the present invention, which includes a S1P1 receptor agonist as an active ingredient, enables the inhibition of formation and/or enlargement of cerebral aneurysm or the regression of cerebral aneurysm, and enables the prevention and/or treatment of a disease associated with cerebral aneurysm.

Abstract: A flash discharge tube includes a cylindrical glass bulb filled with a rare gas; a pair of main electrodes sealed to both ends of the glass bulb via bead glasses; rough surfaces formed at least in the regions to which the bead glasses are welded, the regions being on the outer circumferential surfaces of the pair of main electrodes; and hard microparticles adhered to the rough surfaces. The hard microparticles are embedded in the rough surfaces. This increases the connection strength between the bead glasses and the pair of main electrodes, thereby ensuring the sealing performance between the bead glasses and the pair of main electrodes.

Abstract: To provide an oil-in-water emulsion skin care cosmetic composition which, without the addition of a pharmaceutical agent and a film-forming agent or the like thereto, effects an excellent elastic or resilient feeling to skin and is excellent in non-stickiness and stability. An oil-in-water emulsion skin care cosmetic composition, comprising (a) a paraffin wax and/or a polyethylene wax, (b) a microcrystalline wax, and (c) an animal/plant-derived wax which contains, as the main ingredient thereof, an ester of a higher fatty acid having from 20 to 32 carbon atoms and an alcohol having from 28 to 34 carbon atoms, and has a melting point of from 75 to 100° C., in which the ratio of component (a) to component (b) is from 70/30 to 95/5 (by mass).

Abstract: A flash discharge tube includes a cylindrical glass bulb filled with a rare gas; a pair of main electrodes sealed to both ends of the glass bulb via bead glasses; rough surfaces formed at least in the regions to which the bead glasses are welded, the regions being on the outer circumferential surfaces of the pair of main electrodes; and hard microparticles adhered to the rough surfaces. The hard microparticles are embedded in the rough surfaces. This increases the connection strength between the bead glasses and the pair of main electrodes, thereby ensuring the sealing performance between the bead glasses and the pair of main electrodes.

Abstract: The present invention is a sheet-like cosmetic produced by impregnating a non-woven fabric with a cosmetic comprising (A) 4-methoxysalicylic acid or a salt thereof and (B) a water soluble polysaccharide. It also provides a sheet-like cosmetic that additionally comprises (C) an oil component, (D) an alkyl-modified carboxyvinyl polymer, (E) a water soluble polymer other than said (B) and (D), and (F) hydroxylamine or a derivative thereof. The object of the present invention is to improve the texture upon use, such as the stickiness and the friction, of a sheet-like cosmetic produced by impregnating a non-woven fabric with a cosmetic comprising 4-methoxysalicylic acid or a salt thereof.

Abstract: To provide an oil-in-water emulsion skin care cosmetic composition which, without the addition of a pharmaceutical agent and a film-forming agent or the like thereto, effects an excellent elastic or resilient feeling to skin and is excellent in non-stickiness and stability. An oil-in-water emulsion skin care cosmetic composition, comprising (a) a paraffin wax and/or a polyethylene wax, (b) a microcrystalline wax, and (c) an animal/plant-derived wax which contains, as the main ingredient thereof, an ester of a higher fatty acid having from 20 to 32 carbon atoms and an alcohol having from 28 to 34 carbon atoms, and has a melting point of from 75 to 100° C., in which the ratio of component (a) to component (b) is from 70/30 to 95/5 (by mass).

Abstract: The present invention is a sheet-like cosmetic produced by impregnating a non-woven fabric with a cosmetic comprising (A) 4-methoxysalicylic acid or a salt thereof and (B) a water soluble polysaccharide. It also provides a sheet-like cosmetic that additionally comprises (C) an oil component, (D) an alkyl-modified carboxyvinyl polymer, (E) a water soluble polymer other than said (B) and (D), and (F) hydroxylamine or a derivative thereof. The object of the present invention is to improve the texture upon use, such as the stickiness and the friction, of a sheet-like cosmetic produced by impregnating a non-woven fabric with a cosmetic comprising 4-methoxysalicylic acid or a salt thereof.

Abstract: An iontophoresis device (includes a working electrode assembly and a non-working electrode assembly, each having respective organism contact surfaces. A release liner may be peeled off when it is pulled in one direction along the contact surfaces. A base film may be coupled to a front surface of the release liner and may be sized to cover the front regions of the contact surfaces. A paste layer is attached to the front surface of the base film. The paste layer is peeled from the skin by pulling the base film via the release liner. The paste layer retains a part of the stratum corneum or sebum when removed from the skin.

Abstract: An object of the present invention is to search for a novel medicinal use of a compound having a secretase inhibitory activity. Because the compound having a secretase inhibitory activity has a remarkable inhibitory effect on retinal neuronal cell death, it is useful as a therapeutic agent for a retinal disease typified by retinal vessel occlusion, diabetic retinopathy, ischemic optic neuropathy, macular degeneration, retinitis pigmentosa and Leber's disease or an eye disease accompanied by an optic neuropathy such as glaucoma.